Let's go over some of the news from Tuesday.
For Women's History Month, Alpha Rising is showcasing the women that have conquered Wall St. Today, meet Rosemary McFadden, the first woman to be president of a stock or futures exchange.
As Albertsons prepares to bring a significant piece of Rite Aid into its family, we took a look back at how the grocer became the mega chain it is today.
Stocks were slightly higher.
U.S. equities were higher with the Dow and the S&P 500 closing at new record highs.
Oncolix CEO Michael Redman tells TheStreet how his firm is extending lives by developing treatment for women's cancers. Here's what their biotech innovation has coming down the pipeline.
Lexaria director Chris Bunka knows legal cannabis is coming, and tells TheStreet just how enormous the market could grow.
About 40 million people suffer from lactose intolerance in America. If Ritter Pharmaceuticals has any say, that number will soon be zero.
With a promising treatment for solid tumor cancers coming down its pipeline, Propanc has its sights set on changing the way cancer is treated.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said CVS Health's move to buy Aetna and Disney reportedly renewed interest in various 21 Century FOX assets are defensive deals.